Bacterin secures USD25m financing with OrbiMed
Bacterin International Holdings, a developer of bone graft material and antimicrobial coatings for medical applications, has closed a USD25m non-dilutive financing with an affiliate of OrbiMed Advisors. The financing will enable Bacterin to execute its growth strategy through anticipated profitability. Under the terms of the agreement, Bacterin initially received USD20m
